Cargando…
Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis
BACKGROUND: Venous thromboembolism (VTE) is a common complication in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) and confers significant morbidity and mortality. Both acute and past cytomegalovirus (CMV) infection have been identified as risk factors for VTE...
Autores principales: | King, C., Patel, R., Mendoza, C., Walker, J. K., Wu, E. Y., Moss, P., Morgan, M. D., O’Dell Bunch, D., Harper, L., Chanouzas, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364516/ https://www.ncbi.nlm.nih.gov/pubmed/35948984 http://dx.doi.org/10.1186/s13075-022-02879-7 |
Ejemplares similares
-
The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis
por: Chanouzas, Dimitrios, et al.
Publicado: (2018) -
Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial
por: Chanouzas, Dimitrios, et al.
Publicado: (2016) -
Rituximab 500 mg 6-monthly infusions is an option in maintenance
therapy of ANCA-associated vasculitis
por: Goel, Ruchika, et al.
Publicado: (2021) -
Avoidance of Harm From Treatment for ANCA-Associated Vasculitis
por: King, Catherine, et al.
Publicado: (2017) -
Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis
por: Mendoza, Carmen E., et al.
Publicado: (2019)